EDAP TMS S.A. American Depositary Shares (FOCL) Stock Price
FOCLStock
$4.09
Market Cap$193.12M
P/E—
PEG Ratio—
Div yield—
Beta0.78
FOCL Share Price Chart
Favorite Metrics
Price vs S&P 500 (4W)-2.21%
VGM Score42.87
FOCL Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.20 | -$0.24 | -19.10%(-$0.04) | |
| Q1 2026 | -$0.21 | -$0.24 | -11.63%(-$0.02) | |
| Q4 2025 | -$0.16 | -$0.25 | -62.38%(-$0.10) | |
| Q3 2025 | -$0.26 | -$0.15 | +42.76%(+$0.11) | |
| Q2 2025 | -$0.16 | -$0.17 | -6.17%(-$0.01) |
FOCL Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.89
3.90
3.91
3.91
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
FOCLEDAP TMS S.A. American Depositary Shares | C | C | D | 2.3x | 9.4% | 47.6% | -40.7% | $4.09 |
| MDTMedtronic plc | B | C | B | 3.2x | 3.8% | 65.7% | 18.1% | $94.75 |
| ITGRInteger Holdings Corporation | C | C | A | 2.3x | 11.6% | 26.1% | 9.7% | $126.70 |
| LIVNLivaNova PLC Ordinary Shares | C | B | B | 2.9x | 8.2% | 68.1% | 12.5% | $77.58 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | 3.7x | 88.2% | 58.7% | 12.2% | $70.78 |
| AXGNAxogen, Inc. Common Stock | F | B | B | 8.1x | 14.9% | 74.6% | -11.8% | $34.62 |
| BLFSBioLife Solutions Inc. | F | C | A | 18.4x | 14.9% | 63.9% | 2.9% | $38.61 |
| CNMDCONMED Corporation | B | C | B | 1.0x | 9.8% | 55.8% | 8.0% | $46.72 |
| CBLLCeriBell, Inc. Common Stock | F | A | A | 9.4x | — | 88.9% | -68.6% | $25.04 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | 2.2x | 12.4% | 76.5% | 18.5% | $14.16 |
| CVCapsoVision, Inc. Common Stock | F | D | B | 25.0x | — | 50.9% | -217.1% | $6.53 |
About EDAP TMS S.A. American Depositary Shares
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.